USPTO serial 76179820
OPTIPEG
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEIPZIG, MARC J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with OPTIPEG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J Bunton
DONNA J BUNTON NIXON & VANDERHYE PC1100 N GLEBE RD 8TH FLARLINGTON, VA 22201-4714UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS; POLYMER BEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES, THERAPEUTIC AND DIAGNOSTIC AGENTS AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES, PROTEINS AND PEPTIDES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; MICELLES AND MICELLE-LIKE STRUCTURES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; POLYMER AGGREGATES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; MICROEMULSIONS AND EMULSIONS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF CARRIERS FOR THERAPEUTIC AND DIAGNOSTIC AGENTS; IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF LIPOSOMES, ANTIBODIES AND ANTIBODY FRAGMENTS TO BE USED AS THERAPEUTICS, DIAGNOSTICS, AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES; POLYMER BEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLS FOR USE IN THE MANUFACTURE OF LIPOSOMES, ANTIBODIES AND ANTIBODY FRAGMENTS TO BE USED AS THERAPEUTICS, DIAGNOSTICS, AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES, ANTIBODIES AND ANTIBODY FRAGMENTS FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF CARRIERS FOR THERAPEUTIC AND DIAGNOSTIC AGENTS | ACTIVE | — |
| 003 | COSMETIC AND TOILETRY PRODUCTS CONTAINING POLYMER DERIVATIVES; NAMELY, EAU DE COLOGNE, PERFUMES, SHAVING SOAP, TALCUM POWDER, DENTIFRICES, TOOTHPASTE, ESSENTIAL OILS FOR PERSONAL USE, BATH OILS AND BATH SALTS, DEODORANTS FOR PERSONAL USE, SOAPS, SKIN CREAMS AND SKIN LOTIONS, MOISTURIZING CREAMS, BODY LOTIONS,AFTERSHAVE, LIPSTICK, MASCARA, EYELINER, SKIN CLEANSERS, MAKE-UP POWDERS AND CREAMS; NAIL POLISH; HAIRCARE PRODUCTS, NAMELY, HAIR SHAMPOO, CONDITIONER AND GEL;HAIR COLORANTS AND HAIR SPRAYS; MOUSSES AND BALMS FOR HAIR STYLING AND HAIR CARE | ACTIVE | — |
| 005 | PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLININGS (IL), ESPECIALLY THE IL-i, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-b AND IL-li SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY, GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR, GRANULOCYTE-COLONY STIMULATING FACTOR (ALPHA AND BETAFORMS) AND MACROPHAGE-COLONY STIMULATING FACTOR (ALSO KNOWN AS CSF-1); HAEMOPOIETINS, NAMELY, ERYTHROPOIETIN, HAEMOPOIETIN-ALPHA AND KIT-LIGAND (ALSO KNOWN AS STEM CELL FACTOR OR STEEL FACTOR); INTERFERONS (IFNS), NAMELY, IFNALPHA, IFNBETA, IFNGAMMA; GROWTH FACTORS AND BIFUNCTIONAL GROWTH MODULATORS, NAMELY, EPIDERMAL GROWTH FACTOR, PLATELET-DERIVED GROWTH FACTOR, TRANSFORMING GROWTH FACTOR (ALPHA AND BETA FORMS), AMPHIREGULIN, SOMATOMEDIN-C, BONE GROWTH FACTOR, FIBROBLAST GROWTH FACTORS, INSULIN-LIKE GROWTH FACTORS, HERAPIN BINDING GROWTH FACTORS AND TUMOR GROWTH FACTORS; DIFFERENTIATION FACTORS AND THE LIKE, NAMELY, MACROPHAGE DIFFERENTIATING FACTOR, DIFFERENTIATION INDUCING FACTOR (DIF) AND LEUKAEMIA INHIBITORY FACTOR; ACTIVATING FACTORS, NAMELY, PLATELET ACTIVATING FACTOR; COAGULATION FACTORS SUCH AS FIBRINOLYTIC/ANTICOAGULANT AGENTS INCLUDING HERAPIN AND PROTEASES AND THEIR PRO-FACTORS, NAMELY, CLOTTING FACTORS VII, VIII, IX, X, Xl, XII, ANTITHROMBIN III, PROTEIN C, PROTEIN 5, STREPTOKINASE, UROKINASE, PROUROKINASE,TISSUE PLASMINOGEN ACTIVATOR, FIBRINOGEN AND HIRUDIN; PEPTIDE HORMONES, NAMELY, INSULIN AND CALCITONIN; ENZYMES, NAMELY, SUPEROXIDE DISMUTASE, GLUCOCEREBRSIDASE, ASPARAGINASE AND ADENOSINE DEAMINASE; TRANSCRIPTION FACTORS AND TRANSCRIPTIONAL MODULATORS; CARBOHYDRATES, GLYCOSOAMINOGLYCANS, GLYCOPROTEINS AND POLYSACCHARIDES; LIPIDS, NAMELY, PHOSPHATIDYL-ETHANOLAMINE, PHOSPHATIDYLSERINE AND DERIVATIVES THEREOF; SPHINGOSINE; STEROIDS, NAMELY, CHOLESTEROL AND DERIVATIVES THEREOF; NUCLEOTIDES, NUCLEOSIDES, HETEROCYCLIC BASES, DNA, RNA, SYNTHETIC AND NON-SYNTHETIC OLIGONUCLEOTIDES INCLUDING THOSE WITH NUCLEASE RESISTANT BACKBONES; VITAMINS; ANTIBIOTICS; BACTERISTATIC AND BACTERICIDAL AGENTS;ANTIFUNGAL, ANTHELMINTHIC AND OTHER AGENTS EFFECTIVE AGAINST INFECTIVE AGENTS INCLUDING UNICELLULAR PATHOGENS; SMALL EFFECTOR MOLECULES, NAMELY, OPTIPEGNORADRENALIN, ALPHA ADRENERGIC RECEPTOR LIGANDS,DOPAMINE RECEPTOR LIGANDS, HISTAMINE RECEPTOR LIGANDS, GABA'BENZODIAZEPINE RECEPTOR LIGANDS, SEROTONICRECEPTOR LIGANDS, LEUKOTRIENES AND TRIIODOTHYRONINE; CYTOTOXIC AGENTS SUCH AS DOXORUBICIN, METHOTREXATE AND DERIVATIVES THEREOF; VACCINES, NAMELY, HEPATITIS-BVACCINE, MALARIA VACCINE, MELANOMA VACCINE AND HIV-1 VACCINE; BLOOD GROWTH AND GENE THERAPY PRODUCTS INCLUDING VIRAL VECTORS AND VIRUSES FOR ONCOLYSIS;PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, LIPIDS, NAMELY, PHOSPHATIDYL ETHANOLAMINE, PHOSPHATIDYLSERINE AND DERIVATIVES TTEREOF; SPHINGOSINE; STEROIDS; NAMELY, CHOLESTEROL AND DERIVATIVES THEREOF | ACTIVE | — |
| 010 | CATHETERS; STENTS AND PARTS AND FITTINGS FOR THESE GOODS | ACTIVE | — |
| 035 | TECHNOLOGY LICENSING SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY | ACTIVE | — |
| 042 | RESEARCH AND CONSULTANCY SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PolyMASC Pharmaceuticals Plc
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named OPTIPEG
- Prosecution event ABN2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2003 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 23, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Sep 18, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 23, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2001 | DOCK | ASSIGNED TO EXAMINER | — |